đź“‹ FDA Reference
medrad atd-t interface device
Medrad
Summary: The Medrad ATD-T Interface Device is a medical device used in tumor ablation procedures. It is primarily utilized by interventional radiologists and oncologists for precise tumor treatment.
FDA Clearance Information
Pathway
510K
Number
K974438 ↗
Decision Date
April 30, 1998
Product Code
MOS
Device Class
Class 2
Evidence
0 studies
The Medrad ATD-T Interface Device was cleared via the FDA 510(k) pathway on April 30, 1998. Manufactured by Medrad, it is classified as a Class 2 device under product code MOS.
What It Is
The Medrad ATD-T Interface Device is designed to facilitate the ablation of tumors. It works by interfacing with ablation systems to deliver energy precisely to targeted tumor tissues. This device aids in the destruction of cancerous cells while minimizing damage to surrounding healthy tissue, making it a valuable tool in oncology.
Clinical Applications
This device is commonly used in interventional radiology and oncology settings for the treatment of solid tumors. It is particularly useful in procedures such as radiofrequency ablation, where precise energy delivery is crucial. The device is suitable for use in both inpatient and outpatient settings, catering to adult patients with various types of tumors.
Indications for Use
The FDA-cleared indications for the Medrad ATD-T Interface Device include its use in tumor ablation procedures. It is intended for patients with solid tumors requiring localized treatment to destroy cancerous cells.
Practical Considerations
The device is typically compatible with a range of ablation systems, allowing for flexibility in clinical use. Clinicians should ensure proper sizing and compatibility with the specific ablation equipment being used. Familiarity with the device's interface and controls is essential for effective operation.
Frequently Asked Questions
What is the Medrad ATD-T Interface Device used for?
It is used for tumor ablation procedures, facilitating the precise delivery of energy to destroy cancerous cells.
What specialties typically use this device?
Interventional radiologists and oncologists commonly use this device in tumor ablation procedures.
What are the FDA-cleared indications?
The device is indicated for use in the ablation of solid tumors, providing localized treatment to destroy cancerous tissues.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.